|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Current Assets: | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Total Current Assets | ||||
| Available-for-sale debt securities held in Trust Account, at fair value (no allowance for credit losses, amortized cost $464,793,730 and $456,425,803 as of June 30, 2026 and December 31, 2025, respectively) | ||||
| Other assets | ||||
| Total Assets | ||||
| Current Liabilities: | ||||
| Accrued expenses | ||||
| Notes payable – related party | ||||
| Note payable – related party | ||||
| Payable to related party | ||||
| Total Liabilities | ||||
| Class A ordinary shares subject to possible redemption, 45,000,000 shares issued and outstanding at redemption value of $10.33 and $10.15 per share as of June 30, 2026 and December 31, 2025, respectively | ||||
| Class A Ordinary Shares | ||||
| Total class A ordinary shares subject to possible redemption, 45,000,000 shares issued and outstanding at redemption value of $10.33 and $10.15 per share as of June 30, 2026 and December 31, 2025, respectively | ||||
| Shareholders’ Equity (Deficit): | ||||
| Ordinary shares, value | ||||
| Class A Ordinary Shares | ||||
| Class B Ordinary Shares | ||||
| Accumulated deficit | ||||
| Accumulated other comprehensive income (loss) | ||||
| Total Shareholders’ Equity (Deficit) | ||||
| Total Liabilities, Commitments and Contingencies and Shareholders’ Equity (Deficit) |
Loading...
